The Colorado Molecular Correlates Laboratory (CMOCO) is a state-of-the-art facility, located within the University of Colorado Department of Pathology. The CMOCO Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cancer treatments with targeted therapy allowing for the best in personalized medicine.
Download CMOCO Test Requisition Form
Download CMOCO Specimen Submission Guidelines
Tumors similarly expressing markers that predict response to treatment and are evaluated by the CMOCO Laboratory include:
| Cancer Type |
Molecular Markers |
| Bladder |
UroVysion |
| Breast |
HER2, ER, PR |
| Cervical |
HPV |
| Colon |
KRAS, BRAF, Microsatellite Instability |
| GIST Tumor |
KIT, PDGFRA |
| Head and Neck |
HPV, EBV |
| Lung |
EGFR, KRAS, ALK Rearrangement Testing, HER2 Mutation, ROSI Rearrangement |
| Melanoma |
BRAF, KIT |
| Stomach |
HER2 Amplification |
GYN Tests
digene HC2 HPV DNA Testing
digene HC2 CT/GC DNA Testing
Specimen Submission
Specimens may be sent via FedEx or our available courier services (local samples).
Result Reports
We can arrange secure fax or email reporting according to your preference.
email:CMOCO@ucdenver.edu
Please allow us the opportunity to serve you!